Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“several antibiotics only target processes of growing bacteria (like replication, transcription, translation, or cell wall synthesis), while others are effective on metabolically inactive cells, to establish the basis for combination therapies [33,36,37].”
From Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gompertz, B. (1825) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1825.0026 · Cited by 3,816
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Pseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., & Davies, D. G. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1140-1154.2002 · Cited by 1,691 · cited 3×
“33,35 Cellswithinthe interior of the biofilm, potentially protected from the effects of tobramycin byperipheral cells, mayhave adapted toa more antibiotic-tolerant stateprior todispersal.”
BackgroundDistinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Tseng, B. S., Zhang, W., Harrison, J. J., Quach, T. P., Song, J. L., Penterman, J., Singh, P. K., Chopp, D. L., Packman, A. I., & Parsek, M. R. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12155 · Cited by 466
Smith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B., & Burns, J. L. (2003) · Chest · doi:10.1378/chest.123.5.1495 · Cited by 307
Research works printed but not linked: 43
- Parsek, 2008, Pattern formation in Pseudomonas aeruginosa biofilms, Curr Opin Microbiol, 11, 560, 10.1016/j.mib.2008.09.015 · DOI
- Davies, 2003, Understanding biofilm resistance to antibacterial agents, Nat Rev Drug Discov, 2, 114, 10.1038/nrd1008 · DOI · Paper page
- Hoiby, 2015, ESCMID guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 · DOI · Paper page
- Haagensen, 2006, Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms, J Bacteriol, 189, 28, 10.1128/JB.00720-06 · DOI · Paper page
- Merritt, 2005, Growing and analyzing static biofilms, Curr Protoc Microbiol, 10.1002/9780471729259.mc01b01s00 · DOI · Paper page
- Pamp, 2009, Insight into the microbial multicellular lifestyle via flow-cell technology and confocal microscopy, Cytometry A, 75, 90, 10.1002/cyto.a.20685 · DOI · Paper page
- Clinical and Laboratory Standards Institute, 2013, Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Third Informational Supplement M100-S23
- Moskowitz, 2004, Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis, J Clin Microbiol, 42, 1915, 10.1128/JCM.42.5.1915-1922.2004 · DOI · Paper page
- Kuti, 2003, Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem, J Clin Pharmacol, 43, 1116, 10.1177/0091270003257225 · DOI · Paper page
- Touw, 2007, Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis, J Cyst Fibros, 6, 327, 10.1016/j.jcf.2006.12.007 · doi:10.1016/j.jcf.2006.12.007
- Haagensen, 2015, New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms, Antimicrob Agents Chemother, 59, 4074, 10.1128/AAC.05037-14 · DOI
- Huang, 2014, Determination of meropenem in bacterial media by LC-MS/MS, J Chromatogr B Analyt Technol Biomed Life Sci, 961, 71, 10.1016/j.jchromb.2014.05.002 · DOI
- Heydorn, 2000, Quantification of biofilm structures by the novel computer program COMSTAT, Microbiology, 146, 2395, 10.1099/00221287-146-10-2395 · DOI · Paper page
- Csajka, 2006, Pharmacokinetic-pharmacodynamic modelling: history and perspectives, J Pharmacokinet Pharmacodyn, 33, 227, 10.1007/s10928-005-9002-0 · DOI · Paper page
- Beal, NONMEM User Guides
- Akaike, 1974, A new look at the statistical model identification, IEEE Trans Automat Contr, 19, 716, 10.1109/TAC.1974.1100705 · DOI · Paper page
- Hannan, 1987, Rational transfer function approximation, Statist Sci, 2, 135, 10.1214/ss/1177013343 · DOI
- Schwarz, 1978, Estimating the dimension of a model, Ann Statist, 6, 461, 10.1214/aos/1176344136 · DOI · Paper page
- Purevdorj-Gage, 2005, Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms, Microbiology, 151, 1569, 10.1099/mic.0.27536-0 · DOI · Paper page
- Chan, 1987, Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and tobramycin-resistant strains of Pseudomonas, Diagn Microbiol Infect Dis, 6, 157, 10.1016/0732-8893(87)90101-5 · DOI
- Comber, 1977, Synergy between ticarcillin and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae in vitro and in vivo, Antimicrob Agents Chemother, 11, 956, 10.1128/AAC.11.6.956 · doi:10.1128/aac.11.6.956
- Fass, 1982, Comparative in vitro activities of β-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli, Antimicrob Agents Chemother, 21, 1003, 10.1128/AAC.21.6.1003 · doi:10.1128/aac.21.6.1003
- Lyon, 1986, In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa, Antimicrob Agents Chemother, 30, 25, 10.1128/AAC.30.1.25 · doi:10.1128/aac.30.1.25
- Klausen, 2003, Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms, Mol Microbiol, 50, 61, 10.1046/j.1365-2958.2003.03677.x · DOI · Paper page
- Klausen, 2003, Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants, Mol Microbiol, 48, 1511, 10.1046/j.1365-2958.2003.03525.x · DOI · Paper page
- Shrout, 2006, The impact of quorum sensing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional, Mol Microbiol, 62, 1264, 10.1111/j.1365-2958.2006.05421.x · DOI · Paper page
- Chua, 2016, Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms, Nat Commun, 7, 10750, 10.1038/ncomms10750 · DOI · Paper page
- Webb, 2003, Cell death in Pseudomonas aeruginosa biofilm development, J Bacteriol, 185, 4585, 10.1128/JB.185.15.4585-4592.2003 · DOI · Paper page
- Rollet, 2009, Biofilm-detached cells, a transition from a sessile to a planktonic phenotype: a comparative study of adhesion and physiological characteristics in Pseudomonas aeruginosa, FEMS Microbiol Lett, 290, 135, 10.1111/j.1574-6968.2008.01415.x · DOI
- Vidal, 2007, Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials, J Antimicrob Chemother, 60, 247, 10.1093/jac/dkm193 · DOI · Paper page
- Hilf, 1989, Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients, Am J Med, 87, 540, 10.1016/S0002-9343(89)80611-4 · doi:10.1016/s0002-9343(89)80611-4 · Paper page
- Korvick, 1992, Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy, Antimicrob Agents Chemother, 36, 2639, 10.1128/AAC.36.12.2639 · DOI · Paper page
- Leibovici, 1997, Monotherapy versus β-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study, Antimicrob Agents Chemother, 41, 1127, 10.1128/AAC.41.5.1127 · DOI · Paper page
- Crabtree, 1999, Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients, Arch Surg, 134, 1293, 10.1001/archsurg.134.12.1293 · doi:10.1001/archsurg.134.12.1293
- Bailey, 2002, Aminoglycosides for intra-abdominal infection: equal to the challenge?, Surg Infect (Larchmt), 3, 315, 10.1089/109629602762539544 · DOI
- Paul, 2004, β Lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials, BMJ, 328, 668., 10.1136/bmj.38028.520995.63 · DOI · Paper page
- Walters, 2003, Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin, Antimicrob Agents Chemother, 47, 317, 10.1128/AAC.47.1.317-323.2003 · DOI · Paper page
- Williamson, 2012, Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population, J Bacteriol, 194, 2062, 10.1128/JB.00022-12 · DOI · Paper page
- Stewart, 1996, Theoretical aspects of antibiotic diffusion into microbial biofilms, Antimicrob Agents Chemother, 40, 2517, 10.1128/AAC.40.11.2517 · DOI · Paper page
- Stewart, 1996, Modeling biocide action against biofilms, Biotechnol Bioeng, 49, 445, 10.1002/(SICI)1097-0290(19960220)49:4<445::AID-BIT12>3.0.CO;2-9 · DOI
- Kumon, 1994, A sandwich cup method for the penetration assay of antimicrobial agents through Pseudomonas exopolysaccharides, Microbiol Immunol, 38, 615, 10.1111/j.1348-0421.1994.tb01831.x · DOI · Paper page
- Shigeta, 1997, Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method, Chemotherapy, 43, 340, 10.1159/000239587 · DOI · Paper page
- Nichols, 1988, Inhibition of tobramycin diffusion by binding to alginate, Antimicrob Agents Chemother, 32, 518, 10.1128/AAC.32.4.518 · DOI · Paper page
Cited by
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D. (2023) · Biofilm · doi:10.1016/j.bioflm.2023.100129 · Cited by 170
Soares, A., Alexandre, K., & Etienne, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02057 · Cited by 113
Metadata
- Authors
- Haagensen, J., Verotta, D., Huang, L., Engel, J., Spormann, A. M., & Yang, K.
- Affiliations
- Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800 Kgs Lyngby, Denmark
- Department of Bioengineering and Therapeutic Sciences, University of California San Francisco School of Pharmacy, San Francisco, CA 94143, USA
- Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, CA 94143, USA
- Departments of Medicine and Microbiology/Immunology, University of California San Francisco, San Francisco, CA 94143, USA
- Department of Civil and Environmental Engineering, James H. Clark Center, Stanford University, Stanford, CA 94305, USA
- ORCID
- Yang, Katherine
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-06
- Volume
- 72
- Issue
- 12
- Pages
- 3357-3365
- ISSN
- 0305-7453
- 1460-2091
- Cited by
- 34
- References
- 6
- Language
- en
- Funders
- National Institutes of Health (4R01AI738-05)
- National Institute of Allergy and Infectious Diseases (4R01AI738-05)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms. https://app.cochat.ai/papers/10.1093/jac/dkx288
- The paper
- Haagensen, J., Verotta, D., Huang, L., Engel, J., Spormann, A. M., & Yang, K. (2017). Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkx288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.